Stuart L. Fine - Faculty Biosketch

Stuart L. Fine, MD

Emeritus Professor of Ophthalmology

Department: Ophthalmology

Contact information

3535 Market Street
Suite 701
Philadelphia, PA 19104

Office: 215-615-1553
Fax: 215-615-1550

Email:
stuart.fine@uphs.upenn.edu

Publications

Search PubMed for articles

Links
Search PubMed for articles

Education:
B.A. (Philosophy)
University of Maryland, College Park, MD, 1962.
M.D.
University of Maryland School of Medicine, Baltimore, Maryland. M.D., 1966.

Post-Graduate Training
Straight Medicine Internship, Department of Medicine, University of Maryland Hospital, Baltimore, MD, 1966-1967.
Assistant Resident, Resident, Chief Resident, University of Florida College of Medicine, Gainesville, FL, 1969-1972.
Fellow in Corneal and External Diseases, University of Florida College of Medicine, Gainesville, FL, 1969-1972.
NIH Special Fellow in Retinal Diseases, The Wilmer Ophthalmological Institute, Baltimore, MD, 1972-1973.

Certifications
Maryland Board of Medical Examiners, 1966.
National Board of Medical Examiners, 1967.
Florida Board of Medical Examiners, 1970.
American Board of Ophthalmology, 1974.
Pennsylvania Board of Medical Examiners, 1991.

Permanent link

> Perelman School of Medicine > Faculty > Details

Selected Publications

Deiner-West, M, Hawkins BS, and Collaborative Ocular Melanoma Study (COMS) Study Group. : Changing Current Practice: Implementing Large Multicenter Trials for a Rare Condition. Applied Clinical Trials 11(9): 48-54, 2002.

Kaiser RS, Berger JW, Maguire MG, Shin DS, Ho AC, Javornik NB, Fine SL and the Choroidal Neovascularization Prevention Trial Research Group. : Laser burn intensity and the risk for choroidal neovascularization in the CNVPT Fellow Eye Study. Arch. Ophthalmology 119: 826-832, 2001.

Moy CS, Albert DM, Diener-West M, McCaffrey LD, Scully RE, Willson, MD and the COMS Study Group: Cause-Specific Mortality Coding: Methods in the Collaborative Ocular Melanoma Study COMS Report No. 14. Controlled Clinical Trials 22: 248-262, 2001.

Collaborative Ocular Melanoma Study (COMS) Study Group Report No. 15: Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collabaorative Ocular Melanoma Study (COMS). Arch Ophthalmol 119: 670-676, 2001.

Collaborative Ocular Melanoma Study (COMS) Randomized Trial of I-125 Brachytherapy for Medium Choroidal Melanoma. COMS Report No. 16. Ophthalmology 108: 348-266, 2001.

Collaborative Ocular Melanoma Study (COMS) Study Group. : Report No. 17, COMS Randomized Trial of Iodine 125 Brachytherapy for choroidal melanoma, II, Characteristics of patients enrolled and not enrolled. Arch Ophthalmology 119: 951-965, 2001.